Blood Group B antigen Inhibitors
The chemical class of Blood Group B antigen Inhibitors encompasses compounds that can potentially suppress or modulate the biochemical pathways involved in the synthesis of this antigen. This includes glycosylation inhibitors like Tunicamycin and Swainsonine, glucosidase inhibitors such as Castanospermine and Deoxynojirimycin, and mannosidase inhibitors like Kifunensine, which could affect the processing and maturation of glycoproteins.
Compounds like Benzyl 2-acetamido-2-deoxy-α-D-galactopyranoside, a specific inhibitor of the synthesizing enzyme alpha-1,3-galactosyltransferase, directly target the enzymatic activity responsible for Blood Group B antigen synthesis. 2-Deoxy-D-glucose, by interfering with glycolysis, and Manganese Chloride, by affecting metal-dependent enzymes, could also influence glycosylation processes. Disruptors of protein transport and processing, such as Brefeldin A, Monensin, and Ritonavir, might impact glycoprotein synthesis pathways. PDMP, by inhibiting glycosphingolipid synthesis, could affect related glycosylation pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
An inhibitor of N-linked glycosylation, could potentially interfere with glycoprotein synthesis processes, including those involved in Blood Group B antigen formation. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $135.00 $246.00 $619.00 $799.00 $1796.00 | 6 | |
An inhibitor of glycoprotein processing enzymes, might impact the synthesis of complex glycans, including Blood Group B antigen. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $180.00 $620.00 | 10 | |
A glucosidase inhibitor that could affect glycoprotein processing and potentially influence Blood Group B antigen synthesis. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $72.00 $142.00 | ||
Another glucosidase inhibitor, might impact the glycosylation process, potentially affecting Blood Group B antigen formation. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $132.00 $529.00 $1005.00 $6125.00 | 25 | |
Inhibits mannosidase I, potentially impacting the maturation of glycoproteins and possibly influencing Blood Group B antigen synthesis. | ||||||
Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside | 3554-93-6 | sc-203427 sc-203427A | 100 mg 1 g | $350.00 $3122.00 | 2 | |
A specific inhibitor for alpha-1,3-galactosyltransferase, the enzyme responsible for synthesizing Blood Group B antigen, potentially inhibiting its activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A glucose analog that interferes with glycolysis and could potentially impact glycosylation processes, including Blood Group B antigen synthesis. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $30.00 | ||
Excess manganese can interfere with the activity of metal-dependent enzymes, potentially affecting those involved in glycosylation and Blood Group B antigen synthesis. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts protein transport in cells, which could impact glycoprotein synthesis and potentially inhibit Blood Group B antigen formation. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
An ionophore that disrupts intracellular ion gradients, potentially affecting glycosylation processes. | ||||||